Efficacy of bivalent vaccine against Aeromonas salmonicida and Edwardsiella tarda infections in turbot

In recent years, more than one pathogenic organism has usually been isolated from diseased turbot Scophthalmus maximus, creating a pressing need for the development of combination vaccines to prevent fish diseases brought on simultaneously by various infections. In this study, the inactivated bivalent vaccine of Aeromonas salmonicida and Edwardsiella tarda was prepared by the formalin inactivation method. After challenge with A. salmonicida and E. tarda at 4 weeks post-vaccination in turbot, the relative percentage survival (RPS) of the inactivated bivalent vaccine was 77.1%. In addition, we assessed the effects of the inactivated bivalent vaccine and evaluated the immunological processes after immunization in a turbot model. Serum antibody titer and lysozyme activity of the vaccinated group were both upregulated and higher than that in control group after vaccination. The expression levels of genes (TLR2, IL-1 & beta;, CD4, MHCI, MHCII) that related to antigen recognition, processing and presentation were also studied in the liver, spleen and kidney tissues of vaccinated turbot. All the detected genes in the vaccinated group had a significant upward trend, and most of them reached the maximum value at 3-4 weeks, which had significant differences from the control group, suggesting that antigen recognition, processing and presentation pathway was activated by the inactivated bivalent vaccine. Our study provides a basis for further application of the killed bivalent vaccine against A. salmonicida and E. tarda in turbot, making it good potential that can be applied in aquaculture.

Automated summary

In recent years, combination vaccines have become necessary to prevent fish diseases caused by multiple infections simultaneously. In this study, an inactivated bivalent vaccine was prepared for Aeromonas salmonicida and Edwardsiella tarda. After vaccination, the vaccinated turbot showed a relative percentage survival (RPS) of 77.1% when challenged with A. salmonicida and E. tarda. The study also found that the vaccinated group had upregulated serum antibody titer and lysozyme activity, as well as increased expression levels of genes related to antigen recognition, processing, and presentation.